Charles River Laboratories International, Inc. (CRL)
NYSE
294.59
+1.75 (+0.60%)
Closed
Sep 28, 2026
Day's Range
289.13296.88
52 wk Range
145.47303.31
Financial Statements - CRL - Charles River Laboratories International, Inc.
Revenue
4.01B▼ 0.9%
Net Income
-142.16M▼ 662.1%Net Margin -3.5%
EBITDA
786.81M▼ 1.2%
Free Cash Flow
518.49M▲ 3.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.01B | 4.04B | 4.12B | 3.97B | 3.54B | 2.92B |
| Cost of Goods | 2.69B | 2.71B | 2.62B | 2.51B | 2.20B | 1.85B |
| Gross Profit | 1.32B | 1.33B | 1.50B | 1.46B | 1.33B | 1.07B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 401.13M | 442.34M | 617.26M | 650.97M | 589.86M | 432.72M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -398.55M | -231.52M | 95.53M | 30.52M | -35.89M | 99.98M |
| Pre Tax Income | -99.50M | 93.11M | 581.28M | 622.98M | 480.71M | 447.11M |
| Income Tax | 42.66M | 67.82M | 100.91M | 130.37M | 81.87M | 81.80M |
| Net Income | -142.16M | 25.29M | 480.37M | 492.60M | 398.83M | 365.30M |
| EPS Basic | -2.91 | 0.2 | 9.27 | 9.57 | 7.77 | 7.35 |
| EPS Diluted | -2.91 | 0.2 | 9.22 | 9.48 | 7.6 | 7.2 |
| Basic Shares Outstanding | 49.56M | 51.38M | 51.22M | 50.81M | 50.29M | 49.55M |
| Diluted Shares Outstanding | 49.56M | 51.38M | 51.22M | 50.81M | 50.29M | 49.55M |
| Ebit | 7.52M | 219.40M | 717.99M | 682.27M | 554.62M | 533.54M |
| Ebitda | 786.81M | 796.14M | 1.03B | 986.14M | 820.16M | 768.47M |
| Net Income Continuous Operations | -142.16M | 25.29M | 480.37M | 492.60M | 398.83M | 365.30M |
| Minority Interests | -2.17M | -14.99M | -5.74M | -6.38M | -7.85M | -1M |
| Preferred Stock Dividends | - | 11.90M | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
